Paradigm Shift Therapeutics

BioHealth Innovation Inc. (BHI) serves as an innovation intermediary that facilitates the transition of market-relevant research into commercial success by bridging management, funding, and market opportunities. With a focus on the BioHealth Capital Region, BHI provides a range of programs, including non-dilutive funding assistance and an Entrepreneur-in-Residence program, to support emerging companies in the biotech field. In addition to its core programs, BHI fosters collaboration among partners and stakeholders to drive advancements in health technology. The organization also engages in educational initiatives and hosts events, further solidifying its role as a catalyst for growth within the biohealth industry. Generated from the website

ExoLytics is an early-stage biotechnology company focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases.

Orchid BioVentures is a venture studio dedicated to building biotechnology companies that provide people, capital, and technology necessary to advance novel approaches for patients with unmet needs.